(Q72794734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

pregnancy rate

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

age factor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

contraceptive agents

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

oral hormonal contraceptives

1 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

female contraceptive agent

1 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

pituitary gonadotropins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

reproductive control agents

1 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

contraceptive effectiveness

1 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

author name string

U. J. Gaspard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

M. A. Romus

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

D. Gillain

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

J. Duvivier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

E. Demey-Ponsart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

P. Franchimont

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225622

1 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6225622

1 September 2023

publication date

1 June 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:0010782483900239?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

https://api.elsevier.com/content/article/PII:0010782483900239?httpAccept=text/plain

1 September 2023

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

1 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

577-590

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

29 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Randomized prospective studies on metabolic effects of oral contraceptives

1 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Relationships between chemical structure and biological properties of progestogens

1 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives

1 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Oral Contraceptive and Postmenopausal Estrogen Effects on Lipoprotein Triglyceride and Cholesterol in an Adult Female Population: Relationships to Estrogen and Progestin Potency*

1 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins

1 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity

1 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin

1 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Homologous radioimmunoassay for human prolactin

1 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Chromatographic determination of gonadal steroids on Sephadex LH-20

1 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

The Apparent Free Testosterone Concentration, An Index of Androgenicity

1 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Effect of serum dilution on binding of cortisol to thermolabile and thermostable serum proteins

1 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Immunochemical quantitation of human transcortin

1 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques

1 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Clinical experience with a triphasic oral contraceptive

1 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol

1 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Pharmacodynamic Studies with a New Progestational Substance - Org 2969 - In Combination With Ethinyloestradiol

1 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Clinical and biochemical results during the treatment with marvelon, a new oral contraceptive (author's transl)

1 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release

1 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Effects of oral contraceptive steroids on pituitary prolactin secretion

1 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive

1 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Metabolic effects of the triphasic oral contraceptive Trigynon

1 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding

1 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Free cortisol in human plasma

1 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy

1 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

Effects of ethinylestradiol on the renin-angiotensin-aldosterone-system and on plasma transcortin in women and men

1 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0010-7824(83)90023-9

1 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6225622%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference